Mediators of Inflammation / 2018 / Article / Tab 1

Research Article

Nasal Cytology: A Comparative Study of Two Different Techniques of Processing—Smeared versus Cytocentrifuged Slides

Table 1

Demographics of patients.

Number (%)Sex, males (%)Age, yearsSmoke, yes/ex (%)SNOT-22

All patients10539 (37.1%)57.4 ± 1325 (23.8%)38.6 ± 20.0
 Normal controls10 (9.5%)2 (20.0%)61.3 ± 11.92 (20.0%)21.5 ± 10.7
 AR17 (16.2%)6 (35.3%)58.4 ± 13.63 (17.6%)48.3 ± 20.1
 NARNE/NARES18 (17.1%)7 (38.9%)48.5 ± 16.73 (16.7%)40.6 ± 9.9
 Rhinitis sicca14 (13.3%)063.1 ± 10.93 (21.4%)34.3 ± 12.2
 CRSwNP30 (28.6%)13 (43.3%)58.9 ± 12.68 (26.7%)42.3 ± 22.9
 CRSsNP16 (15.2%)11 (68.8%)57.3 ± 12.16 (37.5%)34.2 ± 24.5

AR: allergic rhinitis; NAR: nonallergic rhinitis; NARNE: nonallergic rhinitis with neutrophils; NARES: nonallergic rhinitis with eosinophils; CRSWNP: chronic rhinosinusitis with polyps; CRSsNP: chronic rhinosinusitis without polyps.

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.